SCHEDULE 13D/A: RTW Investments Boosts Stake in Allurion Technologies Through Strategic Note Conversion

Sentiment:

Amendment to Beneficial Ownership Statement


RTW Investments, a significant shareholder in Allurion Technologies, has increased its beneficial ownership to 34.1% by converting $5.0 million in notes into 1,492,539 common shares, following an amendment to their note purchase agreement.

Capital raiseThe conversion of $5.0 million in Notes into equity effectively acts as a capital raise by reducing debt and increasing the equity base, albeit through a non-cash transaction.The Second Amendment to the Note Purchase Agreement outlines mechanisms for future conversions of up to an additional $5.0 million (Market Cap Condition), $5.0 million (anytime), and $1.0 million monthly (until April 15, 2026), which represent potential future non-cash capital raises through debt-to-equity conversions.
Worse than expectedThe conversion of $5.0 million in notes into 1,492,539 shares at a Floor Conversion Price of $3.35 per share suggests a conversion at a potentially low valuation, which is dilutive to existing shareholders.The granting of additional conversion rights, exempt from previous beneficial ownership limitations, indicates a significant increase in potential future dilution.The ongoing potential for further conversions (up to $5.0 million anytime, and $1.0 million monthly) creates a persistent overhang of potential dilution for the stock.

Summary

  • RTW Investments, LP, along with its affiliated funds (RTW Master Fund, Ltd. and RTW Innovation Master Fund, Ltd.), collectively holds 2,542,603 shares of Allurion Technologies, Inc., representing 34.1% of the outstanding common stock.
  • This beneficial ownership percentage is calculated based on 5,963,549 shares outstanding as of March 24, 2025, plus an additional 1,492,539 shares issued on April 15, 2025.
  • On April 15, 2025, RTW Investments and certain RTW Funds entered into the Second Amendment to the Note Purchase Agreement, which grants them additional conversion rights for their Notes, notably exempting these conversions from the previous 9.99% beneficial ownership limitation.
  • Under this amendment, if a Market Capitalization Condition is triggered, RTW Funds agreed to convert $5.0 million aggregate principal amount of Notes at a Floor Conversion Rate of 298.5075 shares per $1,000 principal amount, equivalent to a price of $3.35 per share, resulting in 1,492,539 shares.
  • On April 16, 2025, RTW Funds delivered, and Allurion Technologies accepted, a conversion notice for this $5.0 million principal amount, leading to the issuance of the 1,492,539 shares.
  • The amendment also provides RTW Funds with further optional conversion rights, including converting up to an additional $5.0 million upon a Market Capitalization Condition trigger (at a mutually agreed rate), converting up to $5.0 million anytime at a 5-Day VWAP Conversion Rate, and a monthly option to convert up to $1.0 million until April 15, 2026, also at the 5-Day VWAP Conversion Rate.
  • RTW Funds have agreed to abstain from voting shares acquired through these additional conversion rights or vote them proportionally to other shareholders, until certain conditions are met, such as a fundamental change or their collective voting power falling below 9.99%.

Sentiment

Score: 4

Explanation: While a major investor increasing their stake can be seen as a positive signal of confidence, the significant dilution from the conversion at a potentially low price, and the ongoing potential for further dilution, weigh negatively on the immediate outlook for existing shareholders. The terms appear more favorable to the investor than to the company's existing equity holders in terms of dilution.

Positives

  • RTW Investments, a significant institutional investor, is increasing its stake, which could signal confidence in Allurion Technologies' long-term prospects.
  • The conversion of $5.0 million in notes into equity reduces the company's debt obligations, potentially improving its balance sheet and financial flexibility.
  • The amended agreement provides a structured mechanism for future potential debt-to-equity conversions, offering a pathway for capital structure adjustments.

Negatives

  • The conversion of notes into shares results in significant dilution for existing shareholders, as 1,492,539 new shares were issued.
  • The conversion price of $3.35 per share (Floor Conversion Rate) may be below the current market price, indicating a discount for the conversion and potentially unfavorable terms for existing shareholders.
  • The ongoing potential for further conversions (up to $5.0 million anytime, and $1.0 million monthly until April 15, 2026) suggests continued potential for future dilution.
  • The voting agreement limits RTW's influence on shares acquired through these new conversion rights, which could be seen as a concession by the investor.

Risks

  • Share Dilution: The conversion of notes into common stock, and the potential for future conversions, will dilute the ownership percentage of existing shareholders.
  • Price Volatility: The conversion rates tied to VWAP (Volume Weighted Average Price) could expose the company to conversions at lower prices if the stock price declines, potentially exacerbating dilution.
  • Market Capitalization Condition: The specific conditions for triggering certain conversions are not fully detailed in this excerpt, which could introduce uncertainty regarding future capital structure changes.
  • Company Discretion: The company retains discretion to accept or reject certain optional conversion notices, which could lead to uncertainty regarding the timing and extent of future capital structure adjustments.

Future Outlook

The Second Amendment to the Note Purchase Agreement provides a framework for potential future conversions of up to an additional $5.0 million in Notes upon a Market Capitalization Condition trigger, up to $5.0 million at any time, and up to $1.0 million monthly until April 15, 2026, offering ongoing flexibility for RTW Funds to convert debt into equity.

Industry Context

This filing indicates a significant debt-to-equity conversion by a major institutional investor in a publicly traded company. Such conversions are common in sectors like biotech and medical devices, where companies often rely on convertible debt for financing, and investors may convert to equity as milestones are met or as part of a strategic investment.

Related Party Transactions

  • The Second Amendment to the Note Purchase Agreement between Allurion Technologies and RTW Investments/RTW Funds, which are significant shareholders, constitutes a related party transaction.
  • The conversion of $5.0 million in Notes into 1,492,539 shares on April 16, 2025, is a transaction with a related party.

Stakeholder Impact

  • Shareholders: Experience dilution due to the issuance of new shares from note conversion, and face potential future dilution from additional conversion rights. The conversion price may be below market, impacting per-share value.
  • Creditors (Noteholders): RTW Funds, as noteholders, are converting debt into equity, reducing their debt exposure and increasing their equity stake, potentially aligning their interests more closely with equity performance.
  • Company (Allurion Technologies): Benefits from a reduction in debt principal by $5.0 million, improving its balance sheet. However, it incurs significant equity dilution. The structured conversion options provide a pathway for future capital structure adjustments.

Next Steps

  • RTW Funds may exercise further optional conversion rights for up to $5.0 million in Notes if the Market Capitalization Condition is triggered.
  • RTW Funds may exercise optional conversion rights for up to $5.0 million in Notes at any time.
  • RTW Funds may exercise monthly optional conversion rights for up to $1.0 million in Notes until April 15, 2026.
  • Allurion Technologies will need to manage the potential future dilution from these conversion rights.

Key Dates

DateDescription
2025-03-24Date as of which 5,963,549 shares were outstanding, as disclosed in the Issuer's Annual Report on Form 10-K.
2025-03-27Date Issuer's Annual Report on Form 10-K was filed with the SEC.
2025-04-15Date of event requiring filing of this statement; RTW Investments and certain RTW Funds entered into the Second Amendment to the Note Purchase Agreement; 1,492,539 shares were issued by the Issuer pursuant to the Conversion Notice.
2025-04-16RTW Funds delivered the Conversion Notice to acquire 1,492,539 shares, which the Company accepted.
2025-04-17Date of filing of this Amendment No. 8 to Schedule 13D.
2026-04-15End date for the monthly optional conversion right of up to $1 million aggregate principal amount of Notes.

Recommendation

hold

Keywords

Allurion Technologies, RTW Investments, SEC Filing, Schedule 13D, Note Conversion, Equity Dilution, Beneficial Ownership, Debt-to-Equity, Convertible Notes, Common Stock, Warrants, Note Purchase Agreement

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.